TP53 and carcinoma: Comparative analysis of mutations between adenomas and carcinomas reveals a stepwise progression initiated by a loss of tumour suppressor APC function, followed by mutations dysregulating the oncogene RAS, and finally the loss of tumour suppressor function p53 with the transition from advanced adenoma to carcinoma [24,25].